Stock comparison
Mettler-Toledo International
Zoetis
Scored across Buffett, Graham, Lynch and Greenblatt - plus a side-by-side metric table covering valuation, quality, growth and balance sheet.
MTD
Mettler-Toledo International
Market cap
$22.29B
Sector
Healthcare
ZTS
Zoetis
Market cap
$34.09B
Sector
Healthcare
Overall winner
Mettler-Toledo International MTD
Wins on the combined sum of fit scores across all four strategies. Per-strategy breakdown below.
Fit scores by strategy
| Strategy | MTD | ZTS | Winner |
|---|---|---|---|
| Warren Buffett | 69B | 64C | MTD |
| Benjamin Graham | 65B | 70B | ZTS |
| Philip Fisher | 63C | 61C | MTD |
| Peter Lynch | 66B | 42D | MTD |
| Joel Greenblatt | 68B | 43D | MTD |
| Charlie Munger | 74B | 69B | MTD |
| Terry Smith | 70B | 73B | ZTS |
Side-by-side metrics
| Metric | MTD | ZTS |
|---|---|---|
| Market cap | $22.29B | $34.09B |
| P/E (TTM) | 25.3x | 11.9x |
| EV/EBIT | 21.6x | 10.8x |
| ROIC (TTM) | 36.09% | 21.79% |
| Gross margin | 57.79% | 70.75% |
| Net margin | 21.4% | 27.79% |
| Revenue CAGR 5y | 2.01% | 5.04% |
| EPS CAGR 5y | 6.12% | 8.88% |
| Debt / Equity | - | 0.1x |
| Dividend yield | 0.0% | 2.77% |
Where each one wins
The metrics with the biggest gap between the two - sorted so the most decisive edges read first.
MTD leads on
- Debt / Equity-vs 0.1x+100%
- ROIC (TTM)36.09%vs 21.79%+40%
ZTS leads on
- Dividend yield2.77%vs 0.0%+100%
- Revenue CAGR 5y5.04%vs 2.01%+60%
- P/E (TTM)11.9xvs 25.3x+53%
- EV/EBIT10.8xvs 21.6x+50%
Related on invest-like
Key terms in this analysis
Educational tool. Fit scores are deterministic projections from public financials onto each investor's published criteria - not personal recommendations or advice.